4basebio Holds General Meeting
Bitget2026/11/06 12:45- 4basebio shareholders passed all resolutions at the November 6, 2026 general meeting, authorizing directors to allot shares for the capital raise.
- Shareholders also approved disapplying pre-emption rights for those allotments.
- Admission of 485,436 VCT Placing Shares is scheduled for November 9, 2026.
- Admission of 3,210,774 Non-VCT Placing Shares, Subscription Shares and Retail Offer Shares is scheduled for November 10, 2026.
- Completion remains conditional on both admissions and the Placing Agreement becoming unconditional without termination before the November 10 admission.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Is AI an engine or a killer? Morgan Stanley provides answers with data: productivity soars, but nearly 90% of the benefits are taken by 12 industries
Morgan Stanley stated that the productivity dividends from AI are concentrated in 12 highly exposed industries, with growth rates reaching twice the twenty-year average. For the first time, signs of job replacement have emerged.
Production Increase Falls Short, Layoffs First! Boeing (BA.US) Cuts 5% of Commercial Airplane Jobs, Delays 737 Monthly Production Target of 47 Aircraft to 2027
Stephanie Pope, head of Boeing's commercial airplanes division, informed employees in an internal memo on Monday that due to obstacles in increasing aircraft production, the division plans to cut 5% of its workforce.
Crypto prices
More
